Corona Remedies Ltd. initial public offer was subscribed 9.33 times at the end of the second day on Tuesday. It was subscribed 0.62 times or 62% on the first day.
The company's IPO, worth Rs 655.37 crore, is entirely an offer-for-sale of 62 lakh shares. The price band for the Corona Remedies IPO has been fixed at Rs 1,008 to Rs 1,062 per share.
A single lot size for the IPO comprises 14 shares. Retail investors are required to apply for at least a single lot size, amounting to an investment of Rs 14,868 per application based on the upper end of the issue price.
The company reported a profit of Rs 46.2 crore on revenue of Rs 346.5 crore for the quarter ended June 2025. For FY25, profit rose 65.1% to Rs 149.4 crore from Rs 90.5 crore the previous year, while revenue increased 18% to Rs 1,196.4 crore from Rs 1,014.5 crore.
JM Financial, IIFL Capital Services and Kotak Mahindra Capital Company are the merchant bankers for the IPO.
Corona Remedies Subscription
Corona Remedies IPO was subscribed 9.33 times at close on Tuesday.
Qualified Institutional Buyers (QIBs): 1.67 times
Non-Institutional Investors (NIIS): 26.80 times.
Retail Individual Investors: 6.37 times.
Employee Reserved: 4.03 times.
Corona Remedies GMP Today
The grey market premium of Corona Remedies was at Rs 270 apiece as 6:19 p.m. The GMP indicates that Corona Remedies could list at Rs 1332 apiece on exchanges, which means a listing gains of 25.42.
Note: GMP does not represent official data and is based on speculation.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
